V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004911 | 220001931 | 1.59 | null | Curative (C) | 2016-10-19 | 2016-10-19 | LI-1 TRIAL | 01 | N | 220027049 | TRIAL |
| 220004912 | 220001932 | 1.7 | 77.8 | Adjuvant (A) | 2016-02-15 | 2016-02-15 | AML17 TRIAL | Y | N | 220027056 | AML17 TRIAL |
| 220004913 | 220001932 | 1.77 | 64.4 | Curative (C) | 2013-04-02 | 2013-04-02 | Trial Unspecified | 01 | N | 220027056 | TRIAL |
| 220004914 | 220001932 | 1.7 | 91.5 | null | 2016-10-06 | 2016-10-06 | AML17 TRIAL | 01 | null | 220027056 | AML17 TRIAL |
| 220004915 | 220001933 | null | 63.1 | null | 2014-01-05 | 2014-01-05 | AML17 TRIAL | 1 | N | 220027062 | AML17 TRIAL |
| 220004916 | 220001933 | 1.8 | 84.4 | Curative (C) | 2016-11-09 | 2016-11-13 | AML17 TRIAL | N | N | 220027062 | AML17 TRIAL |
| 220004917 | 220001933 | 1.68 | null | Palliative (P) | 2015-06-12 | 2015-06-19 | CYTARABINE | N | N | 220027062 | CYTARABINE |
| 220004918 | 220001934 | 1.57 | null | Curative (C) | 2016-11-20 | 2016-12-03 | CYTARABINE | 02 | null | 220027066 | CYTARABINE |
| 220004919 | 220011005 | 1.9 | 79.25 | Not known (9) | 2013-03-28 | 2013-03-30 | Trial Unspecified | 01 | null | 220027070 | TRIAL |
| 220004920 | 220011005 | null | 105 | null | 2016-02-03 | 2016-02-03 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220027070 | CYTARABINE |
| 220004921 | 220001935 | null | 59.2 | null | 2017-08-18 | 2017-08-18 | Trial Unspecified | 01 | N | 220027072 | TRIAL |
| 220004922 | 220001935 | 1.73 | null | Curative (C) | null | 2014-02-10 | AML17 TRIAL | null | null | 220027072 | AML17 TRIAL |
| 220004923 | 220001935 | 1.73 | 90.8 | Radical (R) | 2017-01-12 | 2017-01-12 | Cytarabine Low Dose | 02 | N | 220027072 | CYTARABINE |
| 220004924 | 220001935 | 1.74 | null | Curative (C) | 2013-06-22 | 2013-06-22 | CYTARABINE | N | null | 220027072 | CYTARABINE |
| 220004925 | 220001936 | 1.78 | 81.5 | Palliative (P) | 2014-01-08 | 2014-01-22 | Cytarabine low (10to20mg/m2) IV/SC | null | N | 220027078 | CYTARABINE |
| 220004926 | 220001936 | 1.6 | 80 | Palliative (P) | 2016-12-08 | 2016-12-08 | Trial Unspecified | 1 | null | 220027078 | TRIAL |
| 220004927 | 220001936 | 1.74 | 70.3 | Palliative (P) | 2013-07-11 | 2013-07-11 | CYTARABINE | N | N | 220027078 | CYTARABINE |
| 220004928 | 220001937 | 1.9 | 71 | Palliative (P) | 2015-09-25 | 2015-09-25 | Cytarabine Low Dose | N | N | 220027084 | CYTARABINE |
| 220004929 | 220001937 | 1.79 | null | null | 2016-10-18 | 2016-10-18 | Trial Unspecified | null | null | 220027084 | TRIAL |
| 220004930 | 220001937 | 1.53 | 70.5 | Curative (C) | 2014-03-05 | 2014-03-05 | AML17 TRIAL | 1 | N | 220027084 | AML17 TRIAL |
| 220004931 | 220001937 | 1.68 | 116 | Curative (C) | 2013-06-20 | 2013-06-20 | AML17 TRIAL | 01 | N | 220027084 | AML17 TRIAL |
| 220004932 | 220001937 | 1.6 | null | Disease modification (D) | 2017-06-08 | 2017-06-22 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027084 | CYTARABINE |
| 220004933 | 220001938 | 1.73 | 59.8 | Disease modification (D) | 2016-08-25 | 2016-08-25 | Trial Unspecified | Y | N | 220027097 | TRIAL |
| 220004934 | 220001938 | 1.79 | 58 | null | 2017-03-11 | 2017-03-11 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220027097 | CYTARABINE |
| 220004935 | 220015883 | 1.82 | 0 | Disease modification (D) | 2015-09-15 | 2015-09-15 | Cytarabine Low Dose | N | N | 220027103 | CYTARABINE |
| 220004936 | 220001939 | 1.81 | 66.2 | Curative (C) | 2017-07-29 | 2017-07-29 | AML17 TRIAL | 01 | null | 220027108 | AML17 TRIAL |
| 220004937 | 220001939 | 1.67 | null | Curative (C) | 2015-02-17 | 2015-04-02 | Trial Unspecified | Y | N | 220027108 | TRIAL |
| 220004938 | 220015884 | 1.63 | 62 | Palliative (P) | 2017-07-06 | 2017-07-06 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220027110 | CYTARABINE |
| 220004939 | 220015884 | 1.72 | null | Curative (C) | 2016-07-13 | 2016-07-15 | Cytarabine Low Dose | null | null | 220027110 | CYTARABINE |
| 220004940 | 220015884 | 1.66 | 91.1 | Curative (C) | 2015-06-08 | 2015-06-08 | Trial Unspecified | N | N | 220027110 | TRIAL |
| 220004941 | 220001940 | 1.58 | 74 | Curative (C) | 2016-09-07 | 2016-09-20 | Trial Unspecified | N | N | 220027115 | TRIAL |
| 220004942 | 220001941 | null | 62.4 | Curative (C) | 2015-03-04 | 2015-03-17 | AML17 TRIAL | null | N | 220027120 | AML17 TRIAL |
| 220004943 | 220001941 | 1.58 | null | Disease modification (D) | 2014-06-16 | 2014-06-16 | Cytarabine low (10to20mg/m2) IV/SC | 02 | null | 220027120 | CYTARABINE |
| 220004944 | 220001941 | 1.78 | null | Curative (C) | 2016-12-18 | 2016-12-18 | AML17 TRIAL | N | N | 220027120 | AML17 TRIAL |
| 220004945 | 220001942 | 1.77 | 58.4 | Curative (C) | null | 2013-01-17 | AML17 TRIAL | null | null | 220027132 | AML17 TRIAL |
| 220004946 | 220001943 | 1.84 | 68 | Curative (C) | null | 2018-01-14 | Trial Unspecified | Y | null | 220027135 | TRIAL |
| 220004947 | 220001943 | 1.62 | 70 | Curative (C) | 2016-11-01 | 2016-11-02 | AML17 TRIAL | Y | N | 220027135 | AML17 TRIAL |
| 220004948 | 220001943 | null | 66 | Curative (C) | 2016-07-11 | 2016-07-11 | Trial Unspecified | 01 | N | 220027135 | TRIAL |
| 220004949 | 220001943 | 1.91 | 78.7 | Curative (C) | 2015-04-07 | 2015-04-07 | Trial Unspecified | Y | null | 220027135 | TRIAL |
| 220004950 | 220001943 | 1.67 | null | Palliative (P) | 2013-05-29 | 2013-05-29 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027135 | CYTARABINE |
| 220004951 | 220001943 | 1.88 | 73.7 | Curative (C) | 2016-02-14 | 2016-02-15 | LI-1 TRIAL | 1 | N | 220027135 | TRIAL |
| 220004952 | 220001944 | null | null | null | 2013-10-10 | 2013-10-10 | LI-1 TRIAL | Y | N | 220027147 | TRIAL |
| 220004953 | 220001944 | 1.75 | null | Adjuvant (A) | 2015-02-12 | 2015-02-14 | Cytarabine Low Dose | 2 | N | 220027147 | CYTARABINE |
| 220004955 | 220001945 | 1.52 | 0 | Curative (C) | 2017-06-08 | 2017-06-08 | Trial Unspecified | 1 | N | 220027157 | TRIAL |
| 220004958 | 220001947 | null | 0 | null | 2017-07-27 | 2017-07-27 | Trial Unspecified | Y | N | 220027160 | TRIAL |
| 220004959 | 220001948 | 1.76 | 74.5 | null | null | 2017-05-08 | LI-1 TRIAL | Y | null | 220027162 | TRIAL |
| 220004960 | 220001948 | 1.62 | null | Palliative (P) | 2015-03-15 | 2015-03-15 | Cytarabine Low Dose | 02 | N | 220027162 | CYTARABINE |
| 220004961 | 220001949 | 1.5 | 115.4 | Curative (C) | 2017-04-08 | 2017-04-08 | LI-1 TRIAL | 1 | N | 220027167 | TRIAL |
| 220004962 | 220001949 | null | 97.6 | Curative (C) | 2015-03-27 | 2015-04-13 | LI-1 TRIAL | Y | N | 220027167 | TRIAL |
| 220004963 | 220001950 | 1.58 | 104 | Palliative (P) | 2016-09-11 | 2016-09-11 | Cytarabine Low Dose | 2 | N | 220027169 | CYTARABINE |